Tesamorelin — the one GH secretagogue that actually has RCT data

LTLeo Tanaka· 2 months ago

Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.

tesamorelin is the odd one out among the GH secretagogues — it's actually FDA approved (Egrifta) with phase 3 RCTs behind it. real, replicated, hard endpoint. so far so good.

BUT the approval is only for reducing visceral fat in HIV-associated lipodystrophy. the leap people make is "reduces visceral fat" → general recomp in healthy people, which the data does not cover. tier 1 but narrow. read the indication, not just the headline.

2 Replies

DCDr. Sarah Chen researcher· Expert· 2 months ago

right lesson. the data is real and tier 1, but the approval is narrow (HIV-associated lipodystrophy). generalizing it to healthy recomp is exactly the extrapolation the evidence doesn't support.

Accepted solution

GAGrace A.· Senior· 2 months ago

nice to see it pulled out of the ipamorelin/CJC bucket. people file all GH secretagogues together but tesamorelin is a totally different evidence class.